跳至主要内容
临床试验/ACTRN12620000366954
ACTRN12620000366954尚未招募未知

A randomised control trial of a targeted intervention program for reducing depression, alcohol use, social isolation and suicide in older Australians: The SHADEPlus trial

Professor Frances Kay-Lambkin0 个研究点目标入组 150 人开始时间: 2020年3月16日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
60 Years 至 o limit(—)
性别
All

入选标准

  • 1) 60 years of age or older;
  • 2) Current depressive symptoms (score 5+ on the Geriatric Depression Scale, GDS);
  • 3) Current risky alcohol consumption (score of 2 or more on the short Michigan Alcoholism Screening Test – Geriatric Version, sMAST-GV);
  • 4) Ability and willingness to access the internet.

排除标准

  • 1) Current, acute, high risk of suicide, as measured by the 5-item subscale of the GDS;
  • 2) Acquired brain injury/significant cognitive impairment/insufficient English to prevent informed consent and understand the interventions;
  • 3) Acute psychotic symptoms. Ineligible participants will be provided with referral options.

研究者

发起方
Professor Frances Kay-Lambkin

相似试验